Xalatan Logo
Important Safety Information Prescribing Information Common Questions
Print This Page
Text Size:AAA
Home
How XALATAN Works
XALATAN Side Effects
How to Use XALATAN
For XALATAN Patients
Staying on XALATAN
XALATAN Savings
Vision Matters™
High Eye Pressure and Glaucoma
Risk Factors for Glaucoma
High Eye Pressure and Families
How Is Glaucoma Detected?
Talking to Your Doctor
Tools
Appointment Questionnaire
Eye Pressure and Usage Tracker

Save on XALATAN, and receive information and support from Vision Matters™. Call 1-800-711-2712 to register.
Learn more about Vision Matters™

Site Map

  • Homepage
  • How XALATAN Works
  • XALATAN Side Effects
  • How to Use XALATAN
  • For XALATAN Patients
  • Staying on XALATAN
  • XALATAN Savings
  • Vision Matters™
  • High Eye Pressure and Glaucoma
    • Risk Factors for Glaucoma
    • High Eye Pressure and Families
    • How Is Glaucoma Detected?
    • Talking to Your Doctor
  • Tools
    • Appointment Questionnaire
    • Eye Pressure and Usage Tracker
  • Common Questions
  • Important Safety Information
  • Prescribing Information
  • Privacy Policy
  • Contact Pfizer
  • About Pfizer
  • Terms of Use

For XALATAN Savings Offer, terms and conditions apply.

Explore PfizerPro.com
Indication

XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.

Important Safety Information

Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.

XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.

There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.

The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.

Please see full prescribing information for XALATAN (latanoprost ophthalmic solution).

Need help paying for medicine?  Pfizer has programs that can help.
Site Map Privacy Policy Terms of Use About Pfizer Contact Pfizer

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

© 2012 Pfizer Inc. All rights reserved.

XLU424507-01